US Broker Ratings

Zymeworks Inc. (ZYME): Investor Outlook on a Biotech Powerhouse with 27% Upside Potential

Zymeworks Inc. (NASDAQ: ZYME) is making waves in the biotechnology sector, and with a potential upside of 27.65% based on analyst target prices, investors are taking notice. As a clinical-stage..

Embecta Corp. (EMBC) Stock Analysis: Exploring a 9.87% Potential Upside in the Healthcare Sector

Embecta Corp. (NASDAQ: EMBC), a stalwart in the healthcare sector, is catching the attention of investors with its recent market performance and promising valuation metrics. Known for its specialized focus..

iRadimed Corporation (IRMD) Stock Analysis: Exploring a Strong Return on Equity and Revenue Growth in the Medical Devices Sector

iRadimed Corporation (NASDAQ: IRMD) is a standout in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $920.61 million, this Florida-based company is making waves..

Cronos Group Inc. (CRON) Stock Analysis: Navigating the Highs and Lows in the Cannabis Sector

Cronos Group Inc. (NASDAQ: CRON), a leading player in the burgeoning cannabis industry, is capturing investor attention with its strategic focus on cannabinoid innovation and international market expansion. With a..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A 107% Potential Upside in the Biotech Arena

Enliven Therapeutics, Inc. (NASDAQ: ELVN) is capturing the attention of investors with its promising position in the biotechnology sector. This clinical-stage biopharmaceutical company, headquartered in Boulder, Colorado, specializes in the..

Claritev Corporation (CTEV) Stock Analysis: 27% Upside Potential Amid Healthcare Innovation

Claritev Corporation (NASDAQ: CTEV), a dynamic player in the healthcare sector, is gaining attention with its robust data analytics and technology-enabled solutions aimed at optimizing the cost management, payment, and..

PureTech Health plc (PRTC) Stock Analysis: Exploring a 212.93% Upside with Breakthrough Biotech Innovations

PureTech Health plc (NASDAQ: PRTC) is making waves in the biotechnology sector with its innovative pipeline and potential for significant stock price appreciation. With a market cap of $355.28 million..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Exploring a 62.51% Potential Upside for Investors

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) presents a compelling opportunity for investors with its focus on rare disease treatments and a significant potential upside. The company, based in Deer Park, Illinois,..

Ginkgo Bioworks Holdings, Inc. (DNA): Investor Outlook Amidst a Challenging Biotech Sector

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a pioneering entity in the biotechnology sector, is at the forefront of cell programming and biosecurity. With a market capitalization of $676.06 million, this..

Beta Bionics, Inc. (BBNX) Stock Analysis: A Medical Device Innovator with Robust Growth Potential

Beta Bionics, Inc. (NASDAQ: BBNX) is gaining significant attention from investors due to its innovative approach in the medical devices sector, specifically targeting the diabetes care market. As a commercial-stage..

Nuvation Bio Inc. (NUVB) Stock Analysis: A Biotech with 136% Upside Potential

Nuvation Bio Inc. (NASDAQ: NUVB) is drawing significant attention in the biotechnology sector, particularly for its innovative approaches in oncology. With a market capitalization of $1.09 billion, this clinical-stage biopharmaceutical..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges with 30% Revenue Growth

Investors looking at the healthcare sector might find Sonida Senior Living, Inc. (SNDA) to be a compelling yet complex investment opportunity. Specializing in senior housing communities across the United States,..

CureVac N.V. (CVAC) Stock Analysis: Unlocking Growth Potential in mRNA Technology

CureVac N.V. (CVAC) is a notable player in the biotechnology sector, specializing in the innovative realm of messenger ribonucleic acid (mRNA) technology. Headquartered in Tübingen, Germany, CureVac is at the..

Arcus Biosciences, Inc. (RCUS) Investor Outlook: Exploring a Potential 128% Upside in Biotech Innovation

Arcus Biosciences, Inc. (RCUS), a trailblazer in the biotechnology sector, is capturing the attention of investors with its promising cancer therapy pipeline and notable potential upside. Headquartered in Hayward, California,..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a Challenging Market with a 36% Upside Potential

As individual investors scour the healthcare sector for promising opportunities, Cross Country Healthcare, Inc. (NASDAQ: CCRN) presents itself as a compelling yet complex prospect. Headquartered in Boca Raton, Florida, Cross..

Bioventus Inc. (BVS) Stock Analysis: Exploring a Potential 77% Upside for Investors

Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector specializing in medical devices, is garnering attention from investors due to its promising growth potential and an impressive upside..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating the Healthcare Device Sector with Strategic Insight

Surmodics, Inc. (NASDAQ: SRDX) stands as a notable player within the healthcare sector, specifically in the medical devices industry. With a market capitalization of approximately $460.67 million, this Minnesota-based company..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating the Healthcare Sector with a Modest Upside

InnovAge Holding Corp. (NASDAQ: INNV) operates at the intersection of healthcare and community support, offering a comprehensive suite of services aimed at allowing seniors to live independently. With a market..

COMPASS Pathways Plc (CMPS): Analyst Ratings Indicate a 193% Potential Upside in the Healthcare Sector

COMPASS Pathways Plc (NASDAQ: CMPS) is a name that has been capturing attention within the healthcare sector, particularly among investors eyeing significant potential returns. Operating at the intersection of biotechnology..

Owens & Minor, Inc. (OMI) Stock Analysis: Navigating Challenges with a 10.21% Potential Upside

Owens & Minor, Inc. (NYSE: OMI) stands as a venerable entity in the healthcare sector, with a history dating back to 1882. This U.S.-based medical distribution company operates across two..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds